Federal Testosterone Lawsuits Move Forward, As Bernstein Liebhard LLP Notes Submission of Joint Status Report

Share Article

Hundreds of testosterone treatment lawsuits have been filed in the federal multidistrict litigation on behalf of men who are alleged to have suffered serious cardiovascular side effects due to their use of AndroGel, Axiron, Testim and other testosterone treatments.

Free Case Review
Our Firm is currently investigating a number of claims on behalf of men who allegedly suffered serious cardiovascular side effects due to their use of low testosterone treatments.

Hundreds of testosterone lawsuits (http://www.testosteronelawsuithub.com/) continue to move forward in a federal multidistrict litigation now underway in U.S. District Court, Northern District of Illinois, Bernstein Liebhard LLP reports. According to a Joint Status Report submitted on January 9, 2015, the parties have conferred on a number of matters, including the appropriateness of utilizing a Master Complaint and Answer for the proceeding, and expect to submit a proposed Case Management Order to the Court that addresses these matters at its next conference. The report also indicated that discovery for individual defendants is moving forward, and that the parties have taken steps to facilitate the coordination of the federal testosterone litigation with similar proceedings underway in various state courts. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

“Our Firm is currently investigating a number of claims on behalf of men who allegedly suffered serious cardiovascular side effects due to their use of low testosterone treatments. We are pleased to see that progress is being made in the federal litigation, and will continue to closely monitor developments in these cases,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free case reviews to men who may have been harmed by AndroGel, Axiron, Testim and other low testosterone treatments.

Testosterone Litigations
Court records indicate that the testosterone litigation has been growing since the U.S. Food & Drug Administration (FDA) revealed on January 31, 2014 that it was reviewing the cardiovascular side effects allegedly associated with low testosterone therapy. Plaintiffs involved in this proceeding claim that their use of drugs like AndroGel, Axiron and Testim caused heart attacks, strokes, deep vein thrombosis, pulmonary embolism and other life-threatening heart problems. They further allege that the manufacturers of the medications knowingly concealed these risks from the public, and failed to warn doctors and patients about the potential for these complications. The lawsuits also claim healthy men were induced to use low testosterone treatments by misleading marketing claims that positioned the drugs as effective remedies for symptoms associated with male aging.

Since the FDA issued its communication on testosterone therapies last January, a panel of agency advisors recommended that the drugs’ labels be revised to make clear they have not been shown to lessen symptoms associated with male aging, such as low sex drive, fatigue, and muscle loss. They also recommended that the manufacturers of testosterone replacement therapies be required to conduct studies of their cardiovascular side effects.*

Men who allegedly suffered serious cardiovascular events due to their use of prescription testosterone treatments may be entitled to compensation for their injury-related damages. To learn more about filing a testosterone treatment lawsuit, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

*http://reuters.com/article/2014/09/17/us-usa-health-testosterone-idUSKBN0HC2C320140917, Reuters, September 17, 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website